Mavacamten will decrease the level or influence of ethinylestradiol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Progestin and ethinyl estradiol are CYP3A4 substrates. Mavacamten may lessen systemic exposures of ethinyl estradiol and progestin, which may cause contraceptive failure or an increase in breakthrough bleeding. To attain https://josueayvql.blogdon.net/top-latest-five-wymzya-fe-urban-news-46429010